Value of Multiple Modalities Using the Spectra WaveWriter Spinal Cord Stimulator System

VERITAS - A Study to Demonstrate the Value of Multiple Modalities Using the Spectra WaveWriter™ Spinal Cord Stimulator System in the Treatment of Chronic Pain

To demonstrate the value of multiple modalities and sustained clinically significant pain relief in patients with chronic pain when using the Boston Scientific Spectra WaveWriter Spinal Cord Stimulator (SCS) System.

Key Inclusion Criteria:

• Chronic pain of the trunk and/or limbs
• 22 years of age or older at time of enrollment
• Willing and able to comply with all protocol-required procedures and assessments/evaluations provided in English
• Willing and capable of giving informed consent

Key Exclusion Criteria:

• Any pain-related diagnosis or medical/psychological condition that, in the clinician's best judgment, might confound reporting of study outcomes
• Significant cognitive impairment that, in the opinion of the Investigator, would reasonably be expected to impair the study candidate's ability to participate in the study
• Current systemic infection, or local infection in close proximity to the anticipated surgical field
• Breast-feeding, pregnant or planning to get pregnant during the course of the study or not using adequate contraception
• Previous spinal cord stimulation trial or is already implanted with an active implantable device(s) (e.g. pacemaker, drug pump, implantable pulse generator)
• Participating, or intends to participate, in another clinical trial that may influence the data that will be collected for this study